HIV-1 persistence in CD4 T cells with stem cell-like properties

Nature medicine (Impact Factor: 27.36). 01/2014; 20(2). DOI: 10.1038/nm.3445
Source: PubMed


Cellular HIV-1 reservoirs that persist despite antiretroviral treatment are incompletely defined. We show that during suppressive antiretroviral therapy, CD4(+) T memory stem cells (TSCM cells) harbor high per-cell levels of HIV-1 DNA and make increasing contributions to the total viral CD4(+) T cell reservoir over time. Moreover, we conducted phylogenetic studies that suggested long-term persistence of viral quasispecies in CD4(+) TSCM cells. Thus, HIV-1 may exploit the stem cell characteristics of cellular immune memory to promote long-term viral persistence.

Download full-text


Available from: Sun Hong, Aug 14, 2014
  • Source
    • "In addition, a large number of independent SGAs are required to achieve the same sampling depth as that from multiple independent bulk PCRs. Previous studies that compared the SGA and bulk PCR methodology found no significant differences in the amplified sequence genotypic characteristics (Buzon et al., 2014; Jordan et al., 2010). These comparisons, however, have been in relatively short or genetically constant regions which may limit detection of differences among SGA versus bulk PCR amplified sequences. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent studies suggest that single genome amplification (SGA) as compared to standard bulk PCR and virus stocks from 293 T transfection versus short term passage in peripheral blood mononuclear cells (PBMC) yield a less biased representation of HIV-1 envelope characteristics. In 9 different subjects, genetic diversity, divergence, and population structure was not significantly different among SGA or bulk PCR amplified envelope V1-V3 segments. In these subjects, 293 T transfection derived virus stocks with SGA or bulk PCR amplified envelopes had similar infectivity, replication kinetics, co-receptor usage, and neutralization susceptibility. While PBMC passage as compared to the 293 T derived virus stocks had similar co-receptor usage, PBMC viruses were less neutralization susceptible to some specific antibodies. Our results suggest that the method of envelope sequence amplification, either SGA or bulk PCR, does not have a significant impact on the genotypic and phenotypic properties of the virus envelope quasispecies.
    Full-text · Article · Feb 2015 · Journal of Virological Methods
    • "Alternatively, these integrations might be positively selected by mechanisms that remain to be determined. Individuals receiving cART show increasing numbers of cells with identical viral genomes by SGA, suggesting clonal expansion of a subset of cells bearing integrated proviruses (Buzon et al., 2014; Chomont et al., 2009; Wagner et al., 2013). Two independent groups have recently documented the long-term persistence of expanded clones of cells during therapy with cART (Maldarelli et al., 2014; Wagner et al., 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The barrier to curing HIV-1 is thought to reside primarily in CD4(+) T cells containing silent proviruses. To characterize these latently infected cells, we studied the integration profile of HIV-1 in viremic progressors, individuals receiving antiretroviral therapy, and viremic controllers. Clonally expanded T cells represented the majority of all integrations and increased during therapy. However, none of the 75 expanded T cell clones assayed contained intact virus. In contrast, the cells bearing single integration events decreased in frequency over time on therapy, and the surviving cells were enriched for HIV-1 integration in silent regions of the genome. Finally, there was a strong preference for integration into, or in close proximity to, Alu repeats, which were also enriched in local hotspots for integration. The data indicate that dividing clonally expanded T cells contain defective proviruses and that the replication-competent reservoir is primarily found in CD4(+) T cells that remain relatively quiescent. Copyright © 2015 Elsevier Inc. All rights reserved.
    No preview · Article · Jan 2015 · Cell
    • "Most recently, the newly described stem-like T memory cells (Buzon et al. 2014) and γδ T cells (Soriano-Sarabia et al. 2013) have been reported to harbor latent HIV infection. Virus has long been thought to persist in macrophages, and specific strategies may be required to address persistence within these cells. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Too controversial to discuss only a short time ago, achieving a cure for HIV infection has become a priority in HIV research. However, substantial challenges must be overcome. Among key hurdles to be surmounted is the definition of a reliable, validated model in which to test latency reversal agents (LRAs), as current primary cell models differ in their response to such agents. Animal models such as the HIV-infected humanized BLT mouse and SIV-infected macaque will be essential to study LRAs and to quantify their effects in anatomic reservoirs. Of several potential anatomic reservoirs, the central nervous system presents a significant obstacle, as it is known to harbor persistent HIV infection and is difficult to access for study and therapeutic intervention.
    No preview · Article · Jul 2014 · Journal of NeuroVirology
Show more